Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arctoris
Abingdon, England, United Kingdomblog.arctoris.com ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Preclinical
01
Overview
Arctoris has demonstrated the ability to accelerate early-stage drug discovery using its Ulysses automation/data science platform. The company has active programs in oncology and neurodegeneration at the preclinical/discovery stage, with additional partnered projects spanning multiple therapeutic areas. No clinical results have been published as of June 2025.
- Therapeutic areas
- OtherOncologyNeurologyInfectious Diseases
- Modalities
- Small moleculeRNA therapy (inferred from microRNA research focus)Biologic (inferred from protein science and structural biology capabilities)Antibody (inferred from broad drug discovery platform and typical biotech focus)
- Industry
- Biotech
02
Partnerships
SpiroChem AG – strategic partnership for integrated biology/chemistry drug discovery solutions combining automated biology with advanced chemistry platforms.Cyclica – collaboration on neurodegenerative disease program.InSilico Medicine – collaboration on COVID‑19/JAK inhibitor program.Multiple undisclosed biotech/pharma partners globally across North America, Europe, Asia-Pacific.
Beyond the preview
Go deeper on Arctoris.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arctoris.